RT Journal Article
SR Electronic
T1 DEEP LEARNING TO PREDICT DEGREE OF INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY FROM KIDNEY ULTRASOUND IMAGES – AN ARTIFICIAL INTELLIGENCE APPROACH
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.17.20176958
DO 10.1101/2020.08.17.20176958
A1 Athavale, Ambarish M.
A1 Hart, Peter D.
A1 Itteera, Mathew
A1 Cimbaluk, David
A1 Patel, Tushar
A1 Alabka, Anas
A1 Dunea, George
A1 Arruda, Jose
A1 Singh, Ashok
A1 Rosenberg, Avi
A1 Kulkarni, Hemant
YR 2020
UL http://medrxiv.org/content/early/2020/08/21/2020.08.17.20176958.abstract
AB Background Interstitial fibrosis and tubular atrophy (IFTA) is a strong predictor of decline in kidney function. Non-invasive test to assess IFTA is not available.Methods We trained, validated and tested a deep learning (DL) system to classify IFTA grade from 6,135 ultrasound images obtained from 352 patients who underwent kidney biopsy. Of 6,135 ultrasound images, 5,523 were used for training (n = 5,122) and validation (n = 401) and 612 to test the accuracy of the DL system. IFTA grade scored by nephropathologist on trichrome stained kidney biopsy slide was used as reference standard.Results There were 159 patients (2,701 ultrasound images), 74 patients (1,239 ultrasound images), 41 patients (701 ultrasound images) and 78 patients (1,494 ultrasound images) with IFTA grades 1, 2, 3 and 4, respectively. The deep-learning classification system used masked images based on a 91% accurate kidney segmentation routine. The performance matrices for the deep learning classifier algorithm in the validation set showed excellent precision (90%), recall (76%), accuracy (84%) and F1-score (80%). In the independent test set also, performance matrices showed excellent precision (90%), recall (80%), accuracy (87%) and F1-score of (84%). Accuracy was highest for IFTA grade 1 (98%) and IFTA grade 4 (82%).Conclusion A DL system can accurately predict IFTA from kidney ultrasound image.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge funding support from the Hektoen institute of Medicine, Chicago, IL for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by institutional review board at Cook County Health, Chicago, IL, USA.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJupyter Notebooks with codes and outputs are available from the authors upon reasonable request.